Product Information
DONEPEZIL HCL 23 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.7936 per EA under NDC 68180052709. Its NADAC has been published 475 times since Apr 13, 2016.
FDA first approved this application on Oct 30, 2015.
The High Outlier badge above means this manufacturer's average price in the DONEPEZIL HYDROCHLORIDE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
23 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180052709
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
4/23/2025
Active Ingredients
DONEPEZIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202782FDA Approved
10/30/2015
On Market Since
12/21/2015
Pharmacological Classes
Price Statistics
The NADAC for DONEPEZIL HCL 23 MG TABLET has been published 475 times since Apr 13, 2016, and over the history we have for it it has declined 88.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7936 per EA |
|---|---|
| All-time high | $6.6361 (Apr 13, 2016) |
| All-time low | $0.5251 (Apr 20, 2022) |
| Median price | $0.9150 |
| Average price | $1.2925 |
| Largest weekly change | +59.9% (Feb 23, 2022) |
| Weeks tracked | 475 |
| Tracking since | Apr 13, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-4.7%
5Y
+22.1%
All
-88.0%
Last surveyed May 14, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DONEPEZIL HCL 23 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DONEPEZIL HCL 23 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.7936 per EA (NDC 68180052709), effective May 14, 2025.
How has the price of DONEPEZIL HCL 23 MG TABLET changed over time?
Over the history we have for it, the NADAC for DONEPEZIL HCL 23 MG TABLET has declined 88.0%. It has been tracked across 475 weekly CMS publications since Apr 13, 2016.
What are the highest and lowest recorded NADAC prices for DONEPEZIL HCL 23 MG TABLET?
Since Apr 13, 2016, the NADAC for DONEPEZIL HCL 23 MG TABLET has ranged from a low of $0.5251 (Apr 20, 2022) to a high of $6.6361 (Apr 13, 2016), with a median of $0.9150 per EA.
Are there cheaper alternatives to DONEPEZIL HCL 23 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DONEPEZIL HCL 23 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures DONEPEZIL HCL 23 MG TABLET?
DONEPEZIL HCL 23 MG TABLET (NDC 68180052709) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.